- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Biocon Biologics bags 'ABEA : Bioprocessing Excellence in South Asia' Award
Biocon Biologics was recognized as the winner as it garnered the maximum number of votes from among 70,000 biopharma professionals who participated in the survey.
Bengaluru: Biocon Biologics Ltd, a subsidiary of Biocon Ltd, today announced that it has won the prestigious ‘Bioprocessing Excellence in South Asia’ Award at the Asia-Pacific Bioprocessing Excellence Awards (ABEA) 2023 held in Singapore earlier this month.
Commenting on the development, Kiran Kumar Gandhirajan, Site Head, Biocon Malaysia, said, “We are delighted and proud to receive the ‘Bioprocessing Excellence in South Asia’ Award. It is a recognition of our longstanding expertise in process sciences, state-of-the-art manufacturing capabilities, operational excellence and high standards of quality compliance. These strengths have enabled us to expand patient access to high-quality affordable biosimilars and make a meaningful difference to global healthcare.”
Biocon Biologics was recognized as the winner as it garnered the maximum number of votes from among 70,000 biopharma professionals who participated in the survey.
The annual Asia-Pacific Bioprocessing Excellence Awards organized by IMAPAC, recognize organizations who demonstrate exceptional bioprocessing expertise and the use of best-in-class technologies and practices to achieve biomanufacturing excellence in terms of speed, reduced cost, and superior quality.
Biocon Biologics has developed multiple technology platforms that use various expression systems such as bacteria, yeast, and mammalian cells. ` The Pichia Pastoris platform technology used to express recombinant proteins is a proprietary technology developed by Biocon and used for its recombinant human insulin and insulin analog products.
Medical Dialogues team had earlier reported that Biocon Foundation, the Corporate Social Responsibility (CSR) arm of Biocon Limited, had been awarded the Gold Award in the ‘Diseases Screening Initiative of the Year’ category for its ‘Oral Cancer Screening Program’ by the India Health and Wellness (IHW) Council at the annual IHW Summit & Awards event, held in Mumbai.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751